TNFA

TNF Pharmaceuticals, Inc. TNFA

Trading inactive

Résultat net

EBITDA

P/E Ratio

Capitalisation

Performance

Periode TNFA CHRO CRVO IMVIF APGN CYCC CSCI TVRD TSBX OMGA
6M -72.92 % -94.23 % 13.17 % -90.00 % -38.57 % -88.90 % -40.62 % -84.24 % -1.31 % -88.68 %
YTD -95.48 % -81.33 % 258.30 % -90.00 % -40.75 % -92.85 % -22.34 % -19.39 % -33.95 % -81.77 %
1Y -97.08 % -87.38 % 311.86 % 0.00 % -93.88 % -96.68 % -26.64 % -19.39 % -46.69 % -95.79 %
3Y -97.28 % -97.19 % -8.16 % -100.00 % -96.38 % -99.86 % -64.67 % -19.39 % -96.77 % -97.81 %
5Y -97.28 % -97.19 % -85.00 % -100.00 % -96.38 % -99.95 % -64.67 % -19.39 % -96.77 % -99.11 %
10Y -97.28 % -97.19 % -99.99 % -100.00 % -96.38 % -100.00 % -64.67 % -19.39 % -96.77 % -99.11 %
Depuis le début -97.28 % -97.19 % -100.00 % -100.00 % -96.38 % -100.00 % -64.67 % -19.39 % -96.77 % -99.11 %

Dividende

Cyclacel Pharmaceuticals, Inc.